News & Events about Artivion Inc.
Artivion Follows Recommendation to Stop PROACT Xa Clinical Trial Artivion Follows Recommendation to Stop PROACT Xa Clinical Trial PR Newswire ATLANTA, Sept. 23, 2022 Study Was Evaluating the Use of Apixaban in Patients Treated with Mechanical Aortic Valves ATLANTA, Sept. 23, 2022 /PRNewswire...
Artivion (NYSE:AORT Get Rating) and STRATA Skin Sciences (NASDAQ:SSKN Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, analyst recommendations, institutional ...
Artivion to Participate in Upcoming Investor Conferences Artivion to Participate in Upcoming Investor Conferences PR Newswire ATLANTA, Aug. 3, 2022 ATLANTA, Aug. 3, 2022 /PRNewswire/ --Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today...
Artivion Initiates Enrollment in PERSEVERE Clinical Trial Artivion Initiates Enrollment in PERSEVERE Clinical Trial PR Newswire ATLANTA, July 27, 2022 Study Designed to Evaluate the Safety and Efficacy of the AMDS Hybrid Prosthesis to Treat Acute DeBakey Type I Aortic Dissections & Support...
Simply Wall St
7 months ago
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...